Back to Trades
Iannone Robert
DirectorCIK 0001737329
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Iannone Robert, Director, has filed 9 SEC reports (2025–2026), spread across 3 companies, totaling $4.1M in disclosed volume. Weighing $0 bought versus $1.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 13 | PLRX PLIANT THERAPEUTICS, INC. | Iannone Robert | Director | Other | $0 |
| Jul 13 | PLRX PLIANT THERAPEUTICS, INC. | Iannone Robert | Director | Award | $67.8K |
| Jul 2 | JAZZ Jazz Pharmaceuticals plc | Iannone Robert | EVP, Global Head of R&D & CMO | Tax withheld | $894.8K |
| Jul 1 | AUTL Autolus Therapeutics plc | Iannone Robert | Director | Award | $76.5K |
| Mar 18 | AUTL Autolus Therapeutics plc | Iannone Robert | Insider | Other | $0 |
| Mar 9 | JAZZ Jazz Pharmaceuticals plc | Iannone Robert | EVP, Global Head of R&D & CMO | Tax withheld | $1.2M |
| Mar 2 | JAZZ Jazz Pharmaceuticals plc | Iannone Robert | EVP, Global Head of R&D & CMO | Grant | $0 |
| Jan 21 | JAZZ Jazz Pharmaceuticals plc | Iannone Robert | EVP, Global Head of R&D & CMO | Grant | $708.6K |
| Nov 19 | JAZZ Jazz Pharmaceuticals plc | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | $1.2M |
9 filings